Home » Genentech, Xenon Enter Pain Partnership
Genentech, Xenon Enter Pain Partnership
Xenon Pharmaceuticals formed a strategic alliance worth up to $646 million with Genentech, a member of the Roche Group, to discover and develop compounds and companion diagnostics for the potential treatment of pain.
Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May